Background and Study Objectives

Apuntes

1394 www.thelancet.com/oncology Vol 19 October 2018Articles Lancet Oncol 2018; 19: 1394–403 Published Online August 21, 2018 http://dx.doi.org/10.1016/ S1470-2045(18)30448-0 See Comment page 1273 University of Texas MD Anderson Cancer Center, Houston, TX, USA (Prof M Frumovitz MD, D L Urbauer MS); Laval University, CHU de Quebec, L’Hotel-Dieu de Quebec, Quebec City, QC, Canada (Prof M Plante MD); Duke University Medical Center, Durham, NC, USA (P S Lee MD); Florida Gynecologic Oncology, Fort Lee, FL, USA (S Sandadi MD); Bay Area Gynecology Oncology, San Jose, CA, USA (J F Lilja MD); San Jorge Children’s Hospital, San Juan, Puerto Rico (P F Escobar MD); Sunnybrook Odette Cancer Center, Toronto, ON, Canada (L T Gien MD); and Memorial Sloan-Kettering Cancer Center, New York, NY, USA (Prof N R Abu-Rustum MD) Correspondence to: Prof Michael Frumovitz, Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA mfrumovitz@mdanderson.org Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial Michael Frumovitz, Marie Plante, Pa...